Law360, New York (October 16, 2009) -- A group of California pharmacies and pharmacists has picked up the sword again in its fight to block Pfizer Inc.’s proposed $68 billion buyout of rival Wyeth, filing an amended complaint after a judge ruled the plaintiffs had failed to support their claims that the merger will eliminate competition and stifle innovation in the U.S. prescription drug market.
The group, which buys drugs from Pfizer and Wyeth, lodged its first amended complaint in the U.S. District Court for the Northern District of California on Friday after Judge Maxine...
